2018 American Transplant Congress
Health and Economic Disparities in Waitlist Access and Liver Distribution Policy
1Surgery, Emory University, Atlanta, GA; 2Hepatology, University of Pennsylvania, Philadelphia, PA.
Background:Sociodemographic disparities compound mortality on the liver transplant waitlist, but the relevance of waitlist disparities to mortality and access among the general population remains unclear.Methods:…2018 American Transplant Congress
Demographic and Geographic Differences in the Proportion of Liver Disease Deaths Captured by the Transplant Waitlist in the United States, 2011 – 2015
Background: There are no population-based estimates of the prevalence of end-stage liver disease in the United States, creating challenges in measuring disease burden to inform…2018 American Transplant Congress
The Ethical Turmoil of Imminent Death Donation
Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX.
A. Imminent Death Donation (IDD) is a term to describe organ procurement from a live donor before withdrawal of ventilator support and/or from a patient…2018 American Transplant Congress
Risk of ESRD in Prior Living Kidney Donors
We studied development of End Stage Renal Disease (ESRD) in living kidney donors (LKDs) who donated in the US between 1994 and 2016 (n=123,523), using…2018 American Transplant Congress
Causes of Death among Deceased Donors
Numbers of deceased organ donors changed little from 2006 to 2010, with an average of 7486 donors per year, but have been increasing since 2010.…2018 American Transplant Congress
Prevalence and Impact of CYP3A5 Genomic Variances on Clinical Outcomes among African-American Kidney Transplant Recipients
1Vidant Medical Center, Greenville, NC; 2East Carolina University, Greenville, NC.
Introduction: Kidney transplantation in African American (AA) recipients continues to demonstrate inferior outcomes when compared with other race/ethnicities. Contributing factors encompass differences in pharmacogenomics, and…2018 American Transplant Congress
Early Graft Losses in National PKE Programs: Gone, but Lost Forever?
Background: PKE increases transplants for patients who are highly sensitized or incompatible with intended living donors. Following catastrophes like primary non-function(PNF) or early graft loss,…2018 American Transplant Congress
Impact of Donor Hepatectomy Time during Organ Procurement in Donation after Circulatory Death Liver Transplantation; The United Kingdom Experience
St James University Hospital, Leeds, United Kingdom.
IntroductionNo data exists to evaluate the impact of hepatectomy time (HT) during donation after cardiac death (DCD) procurement on short and long-term outcomes following liver…2018 American Transplant Congress
Outcomes of De Novo Donor Specific Antibodies in Pancreas Transplant Recipients
University of Wisconsin School of Medicine and Public Health, Madison, WI.
Background: Development of de novo donor-specific antibodies (dnDSA) has detrimental effects on kidney graft survival. But, there is limited information about the relationship of dnDSA…2018 American Transplant Congress
Unbiased Sequencing of Urine Cell-Free DNA (cfDNA) to Evaluation Urine Virome and Associated Renal Allograft Damage
Intro: Virus reactivation leading to graft damage is a frequent post-kidney transplant (KTx) complication. Immunosuppressed individuals are at risk for multiple virus infections simultaneously. Current…
American Transplant Congress abstracts